Virtual Patent Marking

The following RxAnte® products, technology or portions thereof (“RxAnte Technology”) are protected in the United States by the US patents specified below. Additional patent applications may be pending.


RxAnte Technology US Patent Number
RxEffect U.S. Patent 10,108,975 B1
U.S. Patent 11,334,902 B1
U.S. Patent 11,842,365 B1
RxAnte Core Analytics/RxAnte Score U.S. Patent 11,244,029 B1
Value of Future Adherence (VFA) U.S. Patent 10,318,897 B1
U.S. Patent 10,706,372 B1
U.S. Patent 11,586,997 B1
U.S. Patent 11,887,027 B1


This page is intended to satisfy virtual patent marking provisions of various jurisdictions and is intended to serve as notice under 35 U.S.C § 287(a) of the Leahy-Smith America Invents Act, also known as the Patent Reform Act of 2011.


Last Updated: 3/12/2024